TY - JOUR T1 - Autoimmune hepatitis and complexities in management JF - Frontline Gastroenterology JO - Frontline Gastroenterol SP - 77 LP - 87 DO - 10.1136/flgastro-2018-101015 VL - 10 IS - 1 AU - Ashnila Janmohamed AU - Gideon M Hirschfield Y1 - 2019/01/01 UR - http://fg.bmj.com/content/10/1/77.abstract N2 - Autoimmune hepatitis (AIH) is a rare heterogenous immune-mediated liver disease that for the majority has effective therapy, usually resulting in excellent prognosis. Treatment is based on immunosuppression using standard therapy with corticosteroids and azathioprine. Second-line therapeutic options exist for those who are non-responders (‘difficult to treat AIH’) or intolerant to standard therapy; however, their use is not standardised, and in addition, there is vast variation in practice and efficacy. Given the rarity of AIH, expertise in its management can be limited to large referral programmes. In this case-based review, we aim to discuss common clinical dilemmas encountered by clinicians managing adult patients with AIH and address the related competencies in the 2010 Gastroenterology curriculum. ER -